NOVO NORDISK A/S revenue breakdown overview

NOVO NORDISK A/S revenue for the last year amounted to 583.95 B MXN, the most of which — 540.80 B MXN — came from its highest performing source at the moment, Diabetes and Obesity Care, the year earlier bringing 437.78 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought NOVO NORDISK A/S 320.64 B MXN, and the year before that — 236.94 B MXN.